Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.

ABSTRACT:

Objectives

To evaluate the role of the topical corticosteroid, mometasone furoate, nasal spray in the treatment of post COVID-19 anosmia.

Methods

A prospective, randomized, controlled trial was conducted among patients with post COVID-19 anosmia. One hundred patients were randomly assigned to two groups; group I included 50 patients received mometasone furoate nasal spray in an appropriate dose of 2 puff (100 μg) once daily in each nostril for 3 weeks with olfactory training, group II included 50 patients were advised to keep on olfactory training only. The assessment of smell was done using (Visual Analog Scale from 0 to 10). All patients were initially evaluated after their recovery from COVID-19 and followed up for 3 weeks. The smell scores were recorded weekly and the du

SUBMITTER: Abdelalim AA 

PROVIDER: S-EPMC7836546 | biostudies-literature | 2021 Mar-Apr

REPOSITORIES: biostudies-literature